Metallobio
Pre-clinicalMBX develops cutting-edge antimicrobial solutions to combat antimicrobial resistance (AMR). Explore our mission, innovations, and partnerships that are shaping a healthier future. Join us in the fight against untreatable infections.
Founded
2019
Focus
Small Molecules
About
MBX develops cutting-edge antimicrobial solutions to combat antimicrobial resistance (AMR). Explore our mission, innovations, and partnerships that are shaping a healthier future. Join us in the fight against untreatable infections.
Company Info
TypePrivate
Founded2019
LocationCambridge, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile